FibroBiologics (FBLG) Common Equity (2022 - 2026)
FibroBiologics' Common Equity came in at $4.64 million for Q2 2026, up 439.1% from $860,000 a year earlier and up 78.3% from the prior quarter.
Analysis
FibroBiologics (FBLG) Common Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, FibroBiologics' Common Equity was $6.16 million, up 125.1% from FY2024.
- Going back by year, Common Equity was $2.74 million in FY2024 (+118.3%), $1.25 million in FY2023 and -$4 million in FY2022.
- The five-year range for quarterly Common Equity is -$4 million (Q4 2022) to $11.35 million (Q2 2023).
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 87.3% over the last six quarters.
- Business Quant data shows FBLG's Common Equity at $2.6 million (Q1 2026), $6.16 million (Q4 2025) and $125,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.17 Bn | 1,135.76 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 633.70 Bn | 552.23 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.94 Bn | 477.06 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 378.10 Bn | 332.47 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 303.72 Bn | 267.71 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 266.46 Bn | 240.15 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.07 Bn | 196.47 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.22 Bn | 168.41 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | 85.49 Bn |
| 10 | FibroBiologics | 6.77 Mn | -8.04 Mn | - | 4.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.64 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 6.16 Mn |
| Sep 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 860,000.00 |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -3.86 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 10.54 Mn |
| Jun 30, 2023 | 11.35 Mn |
| Mar 31, 2023 | 639,000.00 |
| Dec 31, 2022 | -4.00 Mn |
API Access
FibroBiologics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=FBLG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "FBLG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=FBLG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();